Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SANGUINE CORP. (SGNC) -- Ignore unavailable to you. Want to Upgrade?

To: Hyrulean King who wrote (3329)	7/18/1998 3:41:00 AM
From: Mike Ankley	Respond to of 5402

Thomas Drees: coinventor of U.S. patent 4,900,824 Perfluoro hexamethylenetetramine useful in synthetic blood patents.uspto.gov Abstract ------------------------------------------------------------------------ A blood substitute employs combinations of fluoro or perfluorochemicals capable in the presence of emulsifying agents of forming emulsions stable at room temperature and possessing enhanced oxygen carrying capacity; the invention enables preparation of an improved blood substitute, with improved O(2) carrying capacity and stability, as well as lessened anaphylactoid reaction. Cheers Mike